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PAMPsRNA species produced during virus replication are pathogen-associatedmolecular patterns (PAMPs) triggering
cellular innate immune responses including induction of type I interferon expression and apoptosis. Pattern
recognition receptors (PRRs) for these RNAs include the retinoic acid-inducible gene I (RIG-I) like receptors
(RLRs) RIG-I and melanoma differentiation associated gene 5 (MDA5) and the dsRNA dependent protein
kinase (PKR). Currently, poxvirus PAMPs and their associated PRRs are not well characterized. We report that
RNA species generated in vaccinia infected cells can activate MDA5 or RIG-I dependent interferon-β (IFN-β)
gene transcription in a cell type-speciﬁcmanner. These RNA species also induce the activation of apoptosis in a
PKR dependent, but MDA5 and RIG-I independent, manner. Collectively our results demonstrate that RNA
species generated during vaccinia virus replication are major PAMPs activating apoptosis and IFN-β gene
transcription.Moreover, our results delineate the signaling pathways involved in the recognition of RNA-based
poxvirus PAMPs.oratory, Public Health Agency
da R3E 3R2. Fax: +1 204 789
.
lsevier Inc.© 2011 Published by Elsevier Inc.Introduction
Recognition of pathogen-associated molecular patterns (PAMPs)
by host pattern recognition receptors (PRRs) activates innate immune
responses. Double-stranded RNA (dsRNA) is a PAMP which can be
generated inside virus infected cells during viral replication. Several
cytosolic host PRRs have been identiﬁed for these dsRNA species
including the retinoic acid-inducible gene I (RIG-I) like receptors
(RLRs) RIG-I and melanoma differentiation associated gene 5 (MDA5)
and the dsRNA dependent protein kinase (PKR) (Mogensen, 2009).
DsRNA binding to the C-terminal of RIG-I and MDA5 unmasks the
N-terminal caspase recruitment domain (CARD), stimulating CARD-
CARD interactions with IFN-β promoter stimulator 1 (IPS-1) (also
known as MAVS, Cardiff and VISA) (Kawai et al., 2005; Mogensen,
2009). Downstream signaling results in the activation of thetranscription factors NF-κB and IRF3 to coordinate transcription of
genes encoding anti-viral cytokines (Kawai et al., 2005; Meylan et al.,
2005; Paz et al., 2006). MDA5 and RIG-I differentially respond to RNA
virus infection, with MDA5 recognizing picornaviruses and RIG-I
recognizing inﬂuenza viruses and paramyxoviruses (Kato et al., 2006).
MDA5 also recognizes synthetic polyinosinic acid-polycytidylic acid
(pIC), while in vitro transcribed dsRNA is recognized by RIG-I. The
actual ligand recognized by RIG-I may be the 5′-tri-phosphate moiety
of short, blunt dsRNAs (Schlee et al., 2009). RIG-I, MDA5 and IPS-1
have also been reported to regulate apoptosis in a variety of systems
(Besch et al., 2009; Lei et al., 2009).
PKR represents another cytosolic dsRNA sensor capable of
activating innate immune responses. Following binding to dsRNA,
PKR dimerizes and undergoes auto-phosphorylation (Garcia et al.,
2006). PKR then phosphorylates the serine-51 residue of the alpha
subunit of eukaryotic initiation factor 2 (eIF2α) resulting in a global
halt to translation. Infection of cells with a mutant vaccinia virus
lacking the E3L gene results in PKR dependent eIF2α phosphorylation
(Zhang et al., 2008). Similar to RIG-I and MDA5, PKR can also mediate
NF-κB activation and the induction of apoptosis (Bonnet et al., 2006;
Table 1
Cytokine induction by RNA species generated in vaccinia infected cells. HeLa cells were
either mock transfected or transfected with 3 μg of early, late or late+araC RNA
preparations (as described in Materials and methods). Cells were collected at 6 h post-
transfection and 0.75 μg of RNA was reverse transcribed from each sample and real-
time PCR arrays were performed to detect common human cytokines. GAPDH and β-
actin were used as loading controls for normalization. Cytokines displaying a Ct value of
≥35 were deﬁned as not signiﬁcantly detected and excluded from the analysis. Results
are shown as the fold change in expression of transfected cells in comparison to mock
transfected cells.
Cytokines HeLa cell RNA Early RNA Late RNA Late RNA+araC
Interferon family
IFN-β1 5.79 10.37 108.04 5.79
IFN-γ 1.73 4.44 2.21 2.91
IFN-κ 2.02 2.41 2.72 2.14
IFN-α8 2.13 1.62 2.66 −1.06
IFN-α2 1.73 1.76 2.21 6.29
IFN-α1 1.76 2.20 1.91 1.50
Interleukin family
IL19 9.07 19.64 19.43 5.47
IL20 1.65 5.92 14.37 3.69
IL1F7 2.0 6.44 11.78 5.28
IL6 3.58 6.15 11.55 2.27
IL8 2.70 4.05 10.9 1.90
IL1A 2.32 3.99 10.46 1.67
IL22 1.73 9.55 4.36 2.91
IL13 1.54 1.05 8.46 1.75
IL1B 1.83 4.11 4.18 1.34
IL12A 1.46 1.67 2.86 3.29
IL5 1.73 1.76 3.21 2.91
IL1F9 1.73 2.39 2.21 2.91
IL17C 1.82 1.76 2.21 2.91
IL11 1.52 1.96 2.66 1.64
IL21 −1.16 2.16 1.09 2.26
IL7 1.46 2.24 2.09 1.18
IL24 1.63 2.16 2.10 1.70
IL15 1.46 1.85 2.12 1.64
IL10 1.29 1.56 1.83 1.42
IL18 1.26 1.42 1.66 1.33
TXLNA 1.26 1.61 1.41 1.24
IL12B −1.15 1.07 1.40 1.08
IL17B −1.34 −1.32 −1.05 1.24
TNF family
TNF 3.15 6.19 35.98 1.58
LTB 1.73 1.76 3.68 2.91
TNFSF11 2.09 1.23 1.37 3.27
LTA −1.05 1.92 1.20 3.07
TNFSF10 2.74 1.99 2.45 1.35
TNFSF12 −1.18 1.76 1.90 2.43
TNFSF13 1.26 1.81 1.36 1.52
TNFSF13B 1.35 1.10 −1.21 1.40
CD70 1.05 1.74 1.40 1.31
TNFRSF11B 1.04 1.16 1.20 −1.07
TNFSF14 1.00 −1.10 −1.17 −1.18
Bone Morphogenic Proteins
BMP4 −6.5687 1.6756 2.1871 1.4573
INHBA 1.6308 2.6851 4.0668 1.6479
INHA 1.8753 4.6244 2.2144 2.9163
GDF9 3.5394 3.3533 2.1177 1.6969
MSTN 1.7374 1.76 2.2144 3.2197
GDF5 1.7374 1.76 2.2144 3.1688
NODAL 1.0862 1.1004 1.3844 3.0559
BMP3 1.7267 1.7047 2.1447 2.8245
BMP2 1.4102 2.5841 1.8519 1.142
GDF2 2.5123 1.1983 1.662 1.9855
TGFA 1.2609 1.5492 1.4066 2.1818
TGFB2 1.4298 1.7659 2.1221 1.6079
BMP5 −1.3169 −1.3 1.0459 1.8488
GDF11 1.2716 1.6474 1.1479 1.1133
TGFB1 1.2518 1.573 1.3315 1.216
TGFB3 1.1649 1.4571 1.5324 1.2867
BMP8B −1.043 −1.0518 1.4677 1.3471
BMP1 −1.0938 1.212 1.0013 −1.0602
BMP6 −1.1333 −1.5552 −1.0742 1.0288
Table 1 (continued)
Cytokines HeLa cell RNA Early RNA Late RNA Late RNA+araC
PDGF/VEGF Family
FIGF 1.3004 1.3324 2.0243 2.3656
PDGFA 1.3219 1.5483 1.5148 1.3317
Others
FAM3B 1.7374 2.299 13.1574 2.9163
CSF2 1.6068 2.5954 8.0172 1.1546
CSF1 1.2198 1.6594 1.735 1.3139
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2000). Recently, both PKR and MDA5 were shown to regulate IFN-β
expression in response to infection with a Sindbis virus with a point
mutation in the nsP2 protein (Burke et al., 2009).
While the interactions between RNA-based PAMPs of RNA viruses
and their cellular PRRs are well characterized, comparatively less is
known about the role of RNA species generated by DNA viruses as
PAMPs. In the case of poxviruses, dsRNA is thought to be generated
primarily during convergent transcription of intermediate and late
class genes (Boone, et al., 1979; Colby et al., 1971; Ludwig et al., 2006).
Previously, the effect of vaccinia dsRNA species on the induction of
cytokines and apoptosis has been inferred from the phenotypes of
recombinant vaccinia viruses lacking the dsRNA binding protein E3
(vvΔE3L) or expressing E3 mutants lacking dsRNA binding capacity.
Few studies have directly assessed the immuno-stimulatory activity
RNA species generated during vaccinia replication in the absence of
other viral factors such as viral DNA or proteins. It was recently shown
that the dsRNA binding domain of E3, as well as single amino acids
essential for dsRNA binding, also account for the ability of E3 to inhibit
ssRNA and dsDNA induced signaling (Marq et al., 2009). Thus,
although the induction of cytokine expression and apoptosis during
vvΔE3L infection is speculated to be stimulated by viral RNA species, it
is possible that an alternative viral PAMP(s) could be the stimulatory
molecule. Therefore, a more direct model is required to address the
speciﬁc role of RNA species generated in vaccinia infected cells in the
absence of other potential viral PAMPs. To address this, we previously
demonstrated that RNA species generated in vaccinia infected cells
are capable of activating PKR and IFN-β and TNF-α expression
(Myskiw et al., 2009). Subsequently, it was reported that these
vaccinia RNA species activate IFN-β expression in an MDA5
dependent manner in murine cells (Pichlmair et al., 2009).
Here we extend our previous ﬁndings by proﬁling the global
cytokine response resulting from treatmentof cellswith theseRNAs.We
report that in human cells, RIG-I, in addition to MDA5, regulates cell
type-speciﬁc IFN-β gene transcription in response to RNAs generated in
vaccinia infected cells. Furthermore, we demonstrate that these RNA
species induce PKR dependent, but MDA5 and RIG-I independent,
apoptosis. These results provide the strongest evidence to date that RNA
species generated in vaccinia infected cells act as PAMPs triggering
cytokine expression and apoptosis.
Results
RNA species generated during vaccinia virus replication activate
expression of IFN-β and a select group of pro-inﬂammatory cytokines
Previously we reported that RNA species associated with vaccinia
virus replication can activate IFN-β and TNF-α expression and PKR
phosphorylation (Myskiw et al., 2009). In this study, we sought to
further characterize the cellular response to these RNA species. First,
the global induction of cytokines following transfection of these RNA
species into HeLa cells was examined using real time PCR arrays. To
prepare RNA samples for transfection, HeLa cells were mock infected
(HeLa cell RNA) or infected with vvΔE3L-Rev (Arsenio et al., 2008)
and collected at 2 (early RNA) and 8 (late RNA) h post-infection (hpi).
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(araC) to inhibit vaccinia DNA replication and collected at 8 hpi (late
RNA+araC). Total RNA from these samples was extracted, treated
with DNase, and 3 μg of this RNA was transfected back into HeLa cells.
The relative expression of 84 cytokines representing members of the
IFN, interleukin (IL), tumour necrosis factor (TNF), transforming
growth factor and platelet derived growth factor/vascular endothelial
growth factor super-families were determined. Cytokines detected at
a Ct value of ≥35 were scored as not signiﬁcantly expressed and
excluded from the analysis. Expression of the majority of the
cytokines tested was not signiﬁcantly induced by early or late RNA
transfection. However, we observed robust transcriptional activation
of several cytokine genes in cells transfected with RNA isolated from
late stage vaccinia infections (Table 1). In agreement with our
previous report (Myskiw et al., 2009), we found IFN-β expression
was up-regulated 18.7-fold in cells transfected with RNA collected at
late times post-infection as opposed to uninfected total HeLa cell RNA.
Similarly, TNF-α expression was up-regulated 11.4-fold. Induction of
these cytokines by RNA from late stage infections was blocked when
cells from which the RNA was isolated were pre-treated with araC.
Additionally,we identiﬁed several othermembers of the IL familywhich
were transcriptionally activated by late RNA including IL-20, IL-8, IL-13
and IL1A. In general, transfection of cellular RNA alone, or RNA collected
from early stage vaccinia infections poorly activated cytokine gene
transcription. However, expression of several cytokines such as IFN-β,
was also induced to some degree by early RNA transfection.
We next sought to determine whether the cell type in which the
infectionswere done, and the RNAwas collected from, could affect the
ability of the RNA preparation to activate innate immune responses.
To address this, we isolated total RNA from vvΔE3L-Rev infected baby
hamster kidney 21 cells (BHK21) in an identical manner to the
extracts described from human HeLa cells. RNAs isolated from HeLa
and BHK21 cells were transfected back into HeLa cells and the
induction of IFN-β was determined by RT-PCR (Fig. 1A). The
expression of GAPDH was measured as a loading control. We found
that RNA isolated from infected HeLa and BHK21 cells (late RNA) was
equally capable of activating IFN-β gene transcription.
The activation of PKR, as measured by phosphorylation of
threonine-446, was determined by Western blotting in HeLa cells
transfected with the aforementioned RNA preparations (Fig. 1B). We
were only able to detect activated PKR in cells transfected with late
RNA. Furthermore, this activation also correlated with the phosphor-
ylation of eIF2α, a substrate of activated PKR. Again, we observed no
difference in the ability of RNA isolated from infected BHK21 or HeLa
cells to stimulate PKR activity.
We previously reported that digestion of late vaccinia RNA with
RNase III, which degrades dsRNA, abolished the induction of IFN-β by
these RNA preparations (Myskiw et al., 2009). However, the speciﬁc
role of ssRNA species was not examined. Therefore, we digested late
RNA with RNase A under conditions which speciﬁcally degrade ssRNA
but not dsRNA (Fig. 1C). As controls, we produced in vitro transcribed
ssRNA and dsRNA of approximately 800 base-pairs corresponding to
the coding sequence for enhanced green ﬂuorescent protein (EGFP).
Using these conditions, we selectively degraded ssEGFP RNA, but not
dsEGFP RNA. The major 28S and 18S ribosomal ssRNAs in the late
vaccinia RNA sample were also degraded, suggesting the ssRNA in the
late RNA sample was destroyed. We did not detect any virus speciﬁc
RNA bands in our RNA gel, likely because viral RNA species produced
in vaccinia infected cells are very diverse in size and structure (Boone
et al., 1979). Digestion of late RNA with RNase A did not abolish the
stimulatory potential of the RNA sample on IFN-β induction (Fig. 1D).
We also analyzed the presence of vaccinia early, intermediate and
late gene transcripts in the different RNA preparations. We used RT-
PCR to detect vaccinia D12 (early), A1 (intermediate) and A17 (late)
transcripts in the various RNA preparations (Fig. 1E). As expected, D12
was detected in all viral RNA samples. A1 transcripts were detected ineach viral RNA sample, with higher levels detected in late RNA as
compared to early RNA and late RNA collected in the presence of araC.
Although A1 expression should be blocked in the presence of araC, it is
possible that a run-on transcript under the control of an early
promoter proceeds through the A1 locus, resulting in the band
detected in the late RNA+araC sample. Several such run-on
transcripts are expressed from the genomic region adjacent to the
A1 gene (Yang et al., 2010). It is also possible, given the sensitivity of
PCR, that even minute amounts of A1 expressed in the presence of
araC would be detectable. A17 transcripts were detected in late RNA
samples, but were not detected in early RNA preparations and late
RNA collected in the presence of araC.
RNA species generated in vaccinia infected cells can activate cell type-
speciﬁc MDA5 or RIG-I dependent IFN-β expression
Recently it was demonstrated that the induction of IFN-β by RNA
isolated from vaccinia infected cells was dependent on MDA5 in
murine cells (Pichlmair et al., 2009). However, the role of RIG-I was
not investigated. Thus, it remains to be determined if other PRRs can
detect these RNA species. To this end, we tested the role of both RIG-I
and MDA5 in the induction of IFN-β by RNA isolated from vaccinia
infected human HeLa cells. We ﬁrst sought to conﬁrm whether MDA5
and RIG-I dependent signaling are functional in HeLa cells. MDA5 and
PKR have been shown to regulate encephalomyocarditis virus (EMCV)
induced IFN-β expression (Kato et al., 2006; Der and Lau, 1995). We
infected HeLa cells with EMCV for 16 h and isolated total RNA samples
by TRIzol extraction, followed by DNase digestion. HeLa cells were
treated withMDA5, RIG-I and PKR speciﬁc siRNAs, or a combination of
both MDA5 and RIG-I siRNAs to assess the effects of a double
knockdown. As a negative control, cells were also treatedwith amutant
MDA5 siRNA (control siRNA) containing a 2 base-pair mismatch
compared to the targeting MDA5 siRNA. The knock-down efﬁciency
was determined 48 h post-transfection (hpt) by Western blotting
(Fig. 2A). Cells were then transfected with the RNA isolated from EMCV
infected cells. At 6 hpt, RNA was collected for real time PCR. IFN-β
induction in response to EMCV RNAwas signiﬁcantly reduced in MDA5
and PKR siRNA treated cells, but not in RIG-I siRNA treated cells (Fig. 2B).
We next examined the activity of RIG-I dependent signaling. In
vitro transcribed dsRNA has been shown to be a ligand activating RIG-
I, but not MDA5 (Kato et al., 2006). HeLa cells pre-treated with siRNA
speciﬁc to MDA5, RIG-I and PKR or a combination of MDA5 and RIG-I
siRNAs were transfected with in vitro transcribed dsEGFP RNA. IFN-β
induction was signiﬁcantly reduced in RIG-I siRNA treated cells, but
not MDA5 or PKR siRNA treated cells (Fig. 2C). Thus, both MDA5 and
RIG-I dependent induction of IFN-β are functional in HeLa cells.
Next, we sought to determine the sensor(s) for RNA species
generated in vaccinia infected cells. HeLa cells were transfected with
siRNAs targeting MDA5, RIG-I or a combination of MDA5 and RIG-I
siRNAs for 48 h. Cells were then transfected with RNA isolated from
late stage vaccinia infections and collected 6 hpt to analyze IFN-β
expression (Fig. 3A). In comparison to control siRNA treated cells, we
observed a signiﬁcant reduction of IFN-β induction in cells treated
with MDA5 siRNAs, but not in RIG-I siRNA treated cells. IFN-β
expression was further reduced in cells with a combination of MDA5
and RIG-I knockdown compared to cells with a single MDA5
knockdown. We also attempted to determine the role of PKR in
vaccinia RNA induced IFN-β expression but were unable to obtain
conclusive results (data not shown).
To determine whether MDA5 also functions as the primary sensor
of vaccinia RNAs in a different human cell line, we treated human lung
adenocarcinoma epithelial A549 cells with MDA5 or RIG-I siRNAs, or a
combination of both siRNAs, and then transfected the cells with
vaccinia late RNA. The knock-down efﬁciency was determined 48 hpt
by Western blotting (Fig. 3B). Surprisingly, in contrast to HeLa cells,
RNA induced IFN-β expression was signiﬁcantly reduced in RIG-I
Fig. 1. Total RNA isolated from vaccinia infected HeLa and BHK21 cells are comparable in their immuno-stimulatory capacity. (A) Total RNA samples were isolated from vaccinia
infected HeLa and BHK21 cells. HeLa cells were transfected with 3 μg of early, late or late+araC RNA preparations isolated from either infected HeLa or BHK21 cells. IFN-β expression
was measured by RT-PCR at 6 h post-transfection. (B) Duplicate samples as described in (A) were also collected at 6 h post-transfection forWestern blotting. (C) 3 μg of ssEGFP RNA,
dsEGFP RNA and vaccinia late RNAwere incubated at 37 °C for 1 h in RNase A digestion buffer in the absence (mock digested) or presence of 100 ng of recombinant RNase A (RNase A
digested). Electrophoresis of the digested samples was carried out on an RNA gel. (D) Late RNA (3 μg) that was mock digested or digested with RNase A, as described earlier, along
with untreated late RNA, was transfected into HeLa cells using Attractene. IFN-β expression was measured by RT-PCR at 6 h post-transfection. (E) Expression of vaccinia early (D12),
intermediate (A1) and late (A17) transcripts was measured by RT-PCR in each RNA preparation.
186 C. Myskiw et al. / Virology 413 (2011) 183–193siRNA treated A549 cells, even though RIG-I expression was only
moderately reduced by siRNA treatment (Fig. 3C). Treatment of A549
cells with MDA5 siRNAs had no effect on IFN induction. We also
transfected A549 cells with RNA isolated from EMCV infected cells. In
contrast to the HeLa cells, IFN-β inductionwas signiﬁcantly reduced in
RIG-I siRNA treated cells and onlymoderately reduced inMDA5 siRNA
treated cells (Fig. 3D).
RNA species generated in vaccinia infected cells can activate MDA5 or
RIG-I dependent IFN-β expression in HeLa cells of different passage
history
Given the contrasting roles of MDA5 and RIG-I in HeLa and A549
cells, we tested additional variables which may affect the use of PRRsin HeLa cells. Although the HeLa cells used for the aforementioned
experiments have been passaged extensively in our laboratory, we did
not observe any phenotypic changes in cell morphology or papilloma
virus E1, E6 and E7 expression. Nonetheless, we ordered fresh, low
passage HeLa cells from ATCC. We treated these low passage HeLa
cells with siRNAs and then transfected the cells with vaccinia late
RNA. Interestingly, in the low passage HeLa cells, similar to A549 cells,
suppression of RIG-I expression signiﬁcantly reduced the induction of
IFN-β, while suppression of MDA5 expression slightly reduced IFN-β
expression (Fig. 3E). To our knowledge, the only difference between
these cells and the HeLa cells used in the initial experiments is passage
history. We tested if repeated passage of HeLa cells (fresh from ATCC)
would result in phenotypic changes in the use of either RIG-I or MDA5
to sense vaccinia RNAs. Cells tested at passage 5 and passage 10
Fig. 2. RIG-I and MDA5 dependent signaling are functional in HeLa cells. (A) 1.5×105
HeLa cells were seeded in 6-well plates. Cells were then treated with 50 nM control,
PKR, MDA5 or RIG-I siRNAs or a combination of MDA5 and RIG-I siRNAs for 48 h.
Western blotting was performed to determine the efﬁciency of the siRNA knock-down.
(B) HeLa cells were transfected with siRNA as in (A) and then transfected with 100 ng of
RNA from EMCV infected HeLa cells. IFN-β expression was measured by real time PCR 6
h post-transfection. (C) HeLa cells were transfected with siRNA as in (A) and then
transfected with 3 μg of in vitro transcribed dsEGFP RNA. IFN-β expression was
measured by real time PCR 6 h post-transfection. Results are representative of three
independent experiments.
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transfection (data not shown). However, when using these cells
after passage ~20, we found that IFN-β expression was reduced in
MDA5 siRNA treated cells, but not RIG-I siRNA treated cells in a
manner identical to our initial transfection experiments (Fig. 3F vs. A).
We also compared IFN-β expression in HeLa cells following
transfection with vaccinia late RNA isolated from both low and high
passage HeLa cells, as well as A549 cells. We found that the source of
viral RNAs does not seem to contribute to such variance of PRR
preference (data not shown).
We previously reported that the induction of IFN-β following
infection of HeLa cells with a vaccinia virus mutant lacking the dsRNA
binding protein E3 (vvΔE3L) was dependent on IPS-1, IRF3 and NF-κB
p65/p50 expression (Myskiw et al., 2009). We sought to investigate
the role of MDA5 and RIG-I during vvΔE3L infection. First, low passage
HeLa cells were transfected with MDA5 or RIG-I siRNAs and theninfected with vvΔE3L. The induction of IFN-β expression was
measured by real time PCR (Fig. 4A). In comparison to control
siRNA treated cells, IFN-β induction stimulated by vvΔE3L infection
was slightly reduced in MDA5 siRNA treated cells and signiﬁcantly
reduced in RIG-I siRNA treated cells. Next, we tested more extensively
passaged HeLa cells which displayed a MDA5 dependent phenotype
for IFN-β induction following RNA transfection.When these HeLa cells
were treated with siRNAs and infected with vvΔE3L, IFN-β induction
was moderately reduced in MDA5 siRNA treated cells and more
signiﬁcantly reduced in RIG-I siRNA treated cells (Fig. 4B).
Downstream components of the RLR pathway mediate IFN-β expression
in response to vaccinia associated RNAs
The role of downstream components of the MDA5 and RIG-I
pathways were analyzed in a similar manner. High passage HeLa cells
were transfected with siRNAs targeting IPS-1, the adaptor of the
MDA5 and RIG-I pathways, IRF3, NF-κB p65 or NF-κB p50. The knock-
down efﬁciency was analyzed byWestern blotting at 48 hpt (Fig. 5A).
Cells treated with siRNA were then transfected with late RNA and
collected 6 hpt to analyze IFN-β expression (Fig. 5B). The activation of
IFN-β gene transcription, in comparison to control siRNA treated cells,
was signiﬁcantly reduced in cells treated with IPS-1, IRF3, and p65
siRNAs and moderately reduced in p50 siRNA treated cells. We also
treated low passage HeLa cells with the foregoing siRNAs, followed by
vaccinia late RNA transfection. In these HeLa cells, IPS-1, IRF3 andNF-κB
p65 also signiﬁcantly contributed to IFN-β expression (data not shown).
RNA species generated during vaccinia infection activate PKR dependent
apoptosis
Infection of cells with vvΔE3L, but not wild-type vaccinia, induces
apoptosis (Lee and Esteban, 1994). Although this has been speculated
to be a result of free dsRNA present during infection with vvΔE3L, no
studies have directly conﬁrmed the role of RNAs generated in vaccinia
infected cells in inducing apoptosis. RNA isolated from vaccinia
infected HeLa cells was tested for its ability to activate apoptosis by
detecting cleavage of caspase-7 and poly (ADP-ribose) polymerase
(PARP). HeLa cellswith high passage historywere transfectedwith the
previously described RNA preparations. While all the RNA transfec-
tions resulted in a small increase in the cleavage of caspase-7 and
PARP, signiﬁcantly higher levels of cleaved caspase-7 and cleaved
PARP were detected in cells transfected with RNA from late stage
vaccinia infections (Fig. 6A). RNA isolated from cells pre-treated with
araC and collected at a late time post-infection activated caspase-7 and
PARP cleavage to a similar level as seen in mock, HeLa RNA and early
RNA transfected cells.
Induction of apoptosis by these RNA preparations was then
quantiﬁed using propidium iodide staining and ﬂow cytometry to
measure genomic DNA fragmentation. Treatment of cells with
transfection reagent alone, cellular RNA or RNA collected at early
times post-infection increased the percentage of cells undergoing
apoptosis by 13% in comparison to untreated controls (Fig. 6B). RNA
collected at late times post-infection increased the percentage of
apoptotic cells by 31% compared to untreated cells. Thus, the
transfection of late RNA increased the number of apoptotic cells by
18% in comparison to transfection of all other RNA samples. RNA
isolated from araC pre-treated cells only induced the background level
of DNA fragmentation. As a positive control, DNA fragmentation
induced by treatment of cells with pIC was also assessed. We found
that pIC treatment increased DNA fragmentation to a level similar to
late RNA.
We next sought to determine the role, if any, of the cytosolic PRRs,
PKR, MDA5 and RIG-I in this apoptotic response. HeLa cells were
transfected with PKR, MDA5 or RIG-I speciﬁc siRNAs for 48 h. Cells
were then transfected with late RNA and the cleavage of caspase-7
Fig. 3. RNA species generated in vaccinia infected cells activate cell type-speciﬁc RIG-I or MDA5 dependent IFN- β expression. (A) HeLa cells were treated with siRNAs as described in
Fig. 2A. Cells were then transfected with 3 μg of late RNA isolated from vaccinia infected cells. IFN-β expression was measured by real time PCR 6 h post-transfection. (B) A549 cells
were transfected with siRNA as described in Fig. 2A. Western blotting was performed to determine the efﬁciency of the siRNA knock-down. (C) A549 cells were transfected with the
indicated siRNAs for 48 h and then transfected with 3 μg of late RNA. The expression of IFN-βwas quantiﬁed using real-time PCR. (D) A549 cells were transfected with the indicated
siRNAs for 48 h and then transfected with 100 ng of RNA from EMCV infected HeLa cells. The expression of IFN-βwas quantiﬁed using real-time PCR. (E) Fresh, low passage HeLa cells
were treated with the indicated siRNAs for 48 h and then transfected with 3 μg of late RNA. The expression of IFN-β was quantiﬁed using real-time PCR. The foregoing results are
representative of three independent experiments. Error bars represent the mean plus and minus one standard deviation. (F) The same HeLa cells used in (E) were passaged ~20
times in culture and then treated with the indicated siRNAs for 48 h. Cells were then transfected with 3 μg of late RNA and expression of IFN-β was quantiﬁed using real-time PCR.
Error bars represent the mean plus and minus one standard deviation.
188 C. Myskiw et al. / Virology 413 (2011) 183–193and PARP was measured by Western blotting. Treatment of cells with
MDA5 or RIG-I siRNAs had no effect on the cleavage of caspase-7 or
PARP (Fig. 6C). In contrast, cleavage of both caspase-7 and PARP
induced by late RNA was greatly reduced in cells treated with PKR
siRNAs. Similar results were obtained when measuring DNA frag-
mentation induced by late RNA. Treatment of cells with PKR siRNA
reduced DNA fragmentation by 13% in comparison to control siRNA
treated cells (Fig. 6D). This corresponds to approximately a 35%
decrease in the level of apoptosis induced speciﬁcally by late RNA
treatment. In contrast, treatment of cells with MDA5 or RIG-I siRNA
did not reduce the level of DNA fragmentation. Suppression of PKR
expression, but not RIG-I or MDA5, also reduced apoptosis in the low
passage HeLa cells (data not shown).
PKR has been reported to mediate apoptosis induced by a vaccinia
virus lacking the E3L gene (vvΔE3L) (Zhang et al., 2008). Another
report found no effect on vvΔE3L induced apoptosis in cells treated
with MDA5 and RIG-I siRNAs (Zhang and Samuel, 2008). However, in
this study the efﬁciency of the siRNA knock-down of RIG-I and MDA5
was not determined, and thus whether the MDA5 and RIG-I proteinlevels were reduced sufﬁciently to observe a phenotype was not
addressed. We sought to determine if the RLR-independent mode of
apoptosis induced by RNA transfections is also observed with a
vvΔE3L live virus infection wherein free viral dsRNA is believed to
activate apoptosis. Cells were treated with siRNAs targeting PKR,
MDA5 or RIG-I and then infected with vvΔE3L. The siRNA mediated
knock-down efﬁciency was comparable to that shown in Fig. 2A.
Similar to previous reports, we found that cleavage of caspase-7 and
PARP was reduced in vvΔE3L infected cells treated with PKR speciﬁc
siRNAs (Fig. 6E). In contrast, we found that treatment of cells with
MDA5 or RIG-I speciﬁc siRNAs had no effect on caspase-7 or PARP
cleavage.
Discussion
Compared with RNA viruses, considerably less is known about the
sensing of RNAs generated during replication of dsDNA viruses, such
as poxviruses. Deletion of the E3L gene from vaccinia virus results in a
virus (vvΔE3L) which activates cytokine expression and apoptosis
Fig. 4. Both RIG-I and MDA5 mediate IFN-β expression during vvΔE3L infection. Low
passage (A) or high passage (B) HeLa cellswere treatedwith the indicated siRNAs for 48 h.
Cells were then infected with vvΔE3L at an MOI of 5 and the expression of IFN-β was
quantiﬁed using real-time PCR at 10 hpi. Error bars represent the mean plus and minus
one standard deviation. Results are representative of three independent experiments.
Fig. 5. IPS-1, IRF3 and NF-κB p65 regulate IFN-β induction by RNA species generated in
vaccinia infected cells. (A) ~1.5×105 HeLa cells were seeded in 6-well plates. Cells were
treated with 50 nM IPS-1, IRF3, NF-κB p50 or NF-κB p65 speciﬁc siRNAs for 48 h.
Western blotting was performed to determine the efﬁciency of the siRNA knock-down.
(B) Cells were treated as in (A) and transfected with 3 μg of late RNA. IFN-β expression
was measured by real time PCR 6 h post-transfection. Error bars represent the mean
plus andminus one standard deviation. Results are representative of three independent
experiments.
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Deng et al., 2006). The vvΔE3L phenotype is believed to be due to
recognition of free viral dsRNA by the innate immune system which
would usually be sequestered by the E3 protein during wild-type
vaccinia infection. Given that E3 can inhibit IFN-β expression induced
by ssRNA and dsDNA, in addition to dsRNA (Marq et al., 2009), several
vaccinia virus PAMPs may contribute to vvΔE3L induced cytokine
expression. In this study, we have analyzed the speciﬁc role of RNA
species generated during vaccinia infection on the induction of
cytokine expression and apoptosis.
We isolated total RNA from vaccinia infected cells using TRIzol. If
viral proteins such as E3 sequester viral RNA during infection, these
RNA species should be released during extraction and present in the
ﬁnal RNA sample. Upon transfection of these RNA species into HeLa
cells, the vaccinia RNAs should be free to be engaged by host PRRs to
activate innate immunity as viral immuno-modulatory proteins such
as E3 are absent. Moreover, in this system the effect of vaccinia RNAs
are studied in isolation as other viral PAMPs are absent. Therefore, this
approach provides a direct means to study the potential of RNA
species generated during vaccinia infection to serve as PAMPs. It
should be noted that TRIzol extraction of RNA will dissociate RNA-
protein interactions. If an RNA-protein interaction is required for a
complex to be immuno-stimulatory, this effect will be lost following
RNA extraction. We also cannot exclude the possibility that TRIzol
extraction may alter the structure and/or dsRNA content of the
isolated RNA. In addition, the combinatorial effect of other viral
PAMPs and/or factors is excluded from this system. Therefore, while
this system offers the advantage that vaccinia RNAs can be studied in
isolation, it should be noted that this context differs from live virus
infection.
We found that RNA species generated during the late stage of
vaccinia virus replication are potent activators of IFN-β and TNF-α
gene expression, as well as several members of the IL family (Table 1).
However, some cytokines, including IFN-β and IL-19, were also
induced by early RNA. Transcription of early vaccinia genes is believedto produce some dsRNA, although considerably less than transcription
of intermediate and late class genes (Boone et al., 1979; Colby et al.,
1971). Recently, it was reported that early vaccinia gene transcription
can activate PKR in RK13 cells when the K1 protein is absent (Willis
et al., 2010). It was also demonstrated that K1 can inhibit pIC and viral
RNA induced PKR activation. In our system, vaccinia early dsRNA may
potentially be an agonist for MDA5 and/or RIG-I, but the quantity
produced may be insufﬁcient to stimulate signiﬁcant IFN-β expres-
sion. Therefore, the induction cytokines by early RNA may be
explained by small amounts of vaccinia dsRNA present in our early
RNA preparations, which also include some intermediate viral
transcripts (Fig. 1E). We previously described the cytokine response
to vvΔE3L infection (Myskiw et al., 2009) and several comparisons
can be made to the cytokine response to transfected RNA. First, both
vvΔE3L infection and late RNA transfection result in up-regulation of
IFN-β, TNF-α and IL-20. This suggests that RNA species generated in
vaccinia infected cells are responsible for inducing expression of these
cytokines during vvΔE3L infection. In contrast, vvΔE3L infection up-
regulates lymphotoxin A (LTA) expression while RNA transfection
does not. Thus, induction of LTA during virus infectionmay result from
the recognition of an alternative viral PAMP.Wewere unable to detect
expression of vaccinia early (D12), intermediate (G8) or late (H3)
proteins during our RNA transfections (data not shown), suggesting
that viral proteins are not being translated from transfected RNAs.
Thus, the observed induction of cytokines following transfection is
likely due to speciﬁc recognition of RNAs.
MDA5 has been reported to regulate IFN-β induction in cells
transfected with RNA isolated from vaccinia infected cells (Pichlmair
et al., 2009). However, the role of RIG-I in this system was not
addressed. We report that in addition to MDA5, RIG-I, as well as IPS-1,
IRF3 and NF-κB participate in activating IFN-β expression following
vaccinia RNA transfection. One striking observation described in our
report is that the use of PRRs for vaccinia RNAs can be cell type and
Fig. 6. RNA species generated during vaccinia virus replication activate PKR dependent apoptosis. (A) HeLa cells were transfected with 10 μg of early and late RNA isolated from
vaccinia infected cells and collected 12 h post-transfection. The cleavage of caspase 7 and poly (ADP-ribose) polymerase was determined byWestern blotting. (B) Cells were treated
as in (A), and an additional well was transfected with 10 μg of pIC. Cells were collected and washed in PBS at 12 h post-transfection and then lysed in propidium iodide buffer. The
fragmentation of cellular genomic DNA was analyzed by ﬂow cytometry. Shown is the percentage of apoptotic cells undergoing DNA fragmentation. Error bars represent one
standard deviation and results are representative of two independent experiments. (C) HeLa cells were transfected with siRNA as in Fig. 2A. Cells were then transfected with 10 μg of
late RNA and collected at 12 h post-transfection. The cleavage of caspase-7 and PARP was determined by Western blotting. (D) Cells were treated as in (C), collected and washed in
PBS and then lysed in propidium iodide buffer. The fragmentation of cellular genomic DNA was analyzed by ﬂow cytometry. Shown is the percentage of cells undergoing apoptosis.
Error bars represent one standard deviation and results are representative of two independent experiments. (E) HeLa cells were transfected with siRNA as in Fig. 2A. Cells were then
mock infected or infected with vvΔE3L at an MOI of 5 and collected at 8 HPI. The cleavage of caspase 7 and poly (ADP-ribose) polymerase was determined by Western blotting.
Results are representative of three independent experiments.
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for vaccinia RNAs. Although we were only able to moderately reduce
RIG-I protein levels in A549 cells by siRNA treatment, several
observations suggest that the effect of the RIG-I siRNA is not due to
non-speciﬁc effects. First, in high passage HeLa cells, the RIG-I siRNA
has no effect on IFN-β expression. Second, several different RIG-I
siRNAs we tested also only moderately reduce RIG-I protein levels in
A549 cells but signiﬁcantly reduce IFN-β expression (data not shown).
In HeLa cells, RIG-I was the sensor in low passage cells and MDA5 was
the sensor in HeLa cells maintained in culture for longer periods.
Similarly, EMCV RNA was sensed by MDA5 in high passage HeLa cells
and by RIG-I in A549 cells. While we do not currently understand the
basis for this observation, it is possible that an unknown adaptor
protein required for RIG-I or MDA5 dependent IFN-β gene transcrip-
tion is differentially expressed and/or regulated in the two cell linesand potentially under different cellular conditions such as passage
history. Also, unique RNase expression proﬁles may exist in different
cell lines which modify incoming RNAs and affect the use of MDA5 or
RIG-I. For example, RNase L, an antiviral enzyme activated during
vvΔE3L infection (Rivas et al., 1998), can produce RIG-I and MDA5
ligands by cleavage of cellular self-RNAs (Malathi et al., 2007). RNase L
mediated cleavage of hepatitis C virus RNA also produces RNA ligands
which activate RIG-I, but not MDA5 (Malathi et al., 2010). It is possible
that RNase L also cleaves vaccinia RNAs, which could affect their
capacity to activate RIG-I or MDA5. Thus, it is possible that differential
expression of RNase L, or other RNAmodifying factors, in different cell
lines or cellular states could affect PRR speciﬁcity. In the different cell
lines used in this study, we found no signiﬁcant difference in MDA5 or
RIG-I expressionwhich correlated with the use of either PRR (data not
shown).
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transcription following vvΔE3L infection. During vvΔE3L infection,
RIG-I knockdown consistently had a greater effect on IFN-β
expression than did MDA5 knockdown, regardless of the passage
history of the cells (Figs. 4A, B). However, with HeLa cells maintained
in culture over time, RIG-I does not appear to facilitate viral RNA
activated IFN-β expression (Figs. 3A, F). The reason for the difference
between the results from these two approaches is likely the complex
nature of virus infection, wherein numerous viral PAMPs, such as
dsRNA, dsDNA and viral proteins may contribute to overall cytokine
expression.
In addition to suppressing cytokine expression, E3 can also block
vaccinia induced apoptosis (Lee and Esteban, 1994), likely through
the inhibition of PKR function (Zhang et al., 2008). We found that
RNAs generated at late times during vaccinia infection, corresponding
to the time when dsRNA production is maximal, could induce
apoptosis. Also, pre-treatment of cells with araC, an inhibitor of viral
DNA replication blocking intermediate and late viral gene transcrip-
tion, also blocked the activation of apoptosis. We determined that
PKR, but not MDA5 or RIG-I, regulates the apoptotic response to
transfection of cells with RNAs generated during virus infection
(Figs. 6C, D). Cumulatively, these results directly demonstrate that
RNA-based PAMPs of vaccinia trigger the induction of apoptosis
through PKR.
Understanding the molecular structure of RNA-based PAMPs
remains an important aim of the ﬁeld of innate immunity (Nakhaei
et al., 2009). The precise structural nature of vaccinia RNA-based
PAMPs is currently unknown. Transcription of complementary
strands of the vaccinia genome produces RNA transcripts which can
anneal to form RNA molecules consisting of both dsRNA and ssRNA
regions (Boone et al., 1979). These RNAs are also highly variable in
length, and can have a complex, branched structure. Thus, the RNA
species produced in vaccinia infected cells are diverse in the
percentage of dsRNA content and overall structure. Given that
MDA5 and RIG-I recognize different RNA structures, our result that
both MDA5 and RIG-I can recognize vaccinia RNAs is not unexpected.
However, it is novel that vaccinia RNAs may be sensed by either RIG-I
or MDA5 in a cell type/state speciﬁc manner. It is likely that a
combination of RNA length, dsRNA content and structure, and the
presence of terminal phosphate groups collectively affect the
activation of MDA5 and/or RIG-I by these RNAs. Whether the majority
of these RNA species have the capacity to stimulate IFN-β expression
or if only a small number of these RNAs with unique structures are
immuno-stimulatory is not known. A recent study demonstrated that
the stimulatory potential of vaccinia RNAs resides in high molecular
weight complexes composed of ssRNA and dsRNA (Pichlmair et al.,
2009). However, whether the ssRNA component of the complex was
required for the stimulation of IFN-β expression was not determined.
Using RNase A to selectively degrade ssRNA, we provide evidence that
ssRNAs in vaccinia infected cells do not contribute to the induction of
IFN-β (Fig. 1D). Thus, dsRNAs generated late during vaccinia infection
are likely the primary PAMP activating IFN-β expression. It will be of
interest to further characterize the structure of these RNA-based
PAMPs of vaccinia.
In summary, we have identiﬁed RNA species generated at the late
stage of vaccinia virus replication as PAMPs activating IFN-β
expression and apoptosis. Moreover, we have found that both
MDA5 and RIG-I are key PRRs of the IFN-β response to these RNA
species. The use of PRRs for vaccinia RNAs appears to be cell type and
cell state-speciﬁc in regards to HeLa and A549 cells. Furthermore, we
found that PKR, but not the RLRs, plays amajor role in the activation of
apoptosis induced by vaccinia RNAs. Collectively, these results help
deﬁne the molecular mechanisms by which cellular PRRs engage
RNA-based PAMPs produced within vaccinia infected cells and will
contribute to the understanding of how vaccinia virus evades immune
recognition.Materials and methods
Cell culture and viruses
HeLa, A549 and BHK21 cells were maintained in Dulbecco's
Modiﬁed Eagle Medium (Gibco), supplemented with 10% fetal calf
serum and 1% penicillin/streptomycin, at 37 °C, 5% CO2. The E3L
deletion mutant (vvΔE3L) vaccinia virus (Copenhagen strain) lacking
the E3L gene was constructed as previously described (Arsenio et al.,
2008). The revertant (vvΔE3L-Rev) vaccinia virus is based on vvΔE3L
with the E3L gene cloned back into the E3L locus.
HeLa cell passage
Over the course of passaging, HeLa cells were maintained in the
conditions described earlier. Cells were split when they reached ~90%
conﬂuency by removing the culture media, washing the cells in
phosphate buffered saline, and dissociating the cells at 37 °C with
TrypLE Express (Gibco). Approximately 15–20% of the cells were used
to seed the subsequent passage.
Antibodies and reagents
Antibodies for total PKR, cleaved caspase-7 and cleaved PARP were
purchased from Cell Signaling Technologies. EIF2α antibodies were
from Biosource. Phospho-speciﬁc PKR (Thr446), and antibodies for
total IRF3, NF-κB p65 and NF-κB p50 were from Epitomics. IPS-1
antibody was obtained from Bethyl Laboratories and the β-actin
antibody was from Sigma. The MDA5 antibody was purchased from
Alexis Biochemicals. The RIG-I antibody was a generous gift from Dr.
Rongtuan Lin, University of McGill. Polyinosinic acid-polycytidylic
acid (pIC) was purchased from GE Healthcare.
Transfections
Small interfering RNA (siRNA): ~1.5×105 HeLa cells were seeded in
6-well plates. Cells were transfected with 50 nM of siRNA (Dharma-
con) using HiPerFect (Qiagen). For the MDA5/RIG-I double knock-
down, cells were transfected with each siRNA at 25 nM. The PKR
siRNA sequencewas 5′-GCGAGAAACUAGACAAAGU-3′. TheMDA5 siRNA
sequence was 5′-CAAUGAGGCCCUACAAAUU-3′. The control siRNA
sequence is identical to the MDA5 sequence with a two base-pair
mismatchhighlighted inbold: 5′-CAACCAGGCCCUACAAAUU-3′. TheRIG-
I siRNA sequence was 5′-CCACAACACUAGUAAACAA-3′. The IPS-1 siRNA
target sequence was 5′-CAUCCAAAGUGCCUACUAG-3′. The IRF3 siRNA
target sequence was 5′-AGACAUUCUGGAUGAGUUA-3′. The NF-κB p65
siRNA target sequencewas 5′-GGAUUGAGGAGAAACGUAA-3′. TheNF-κB
p50 siRNA target sequence was 5′-GAUGGGAUCUGCACUGUAA-3′.
Isolation and transfection of viral RNA
Conﬂuent HeLa or BHK21 cells were infected with vvΔE3L-Rev at a
multiplicity of infection (MOI) of 5 and collected at 2 (early RNA) and
8 (late RNA) hpi. Cells were also pre-treated with 50 μg/mL of araC,
infected with vvΔE3L-Rev (in the presence of araC) and collected at
8 hpi (late RNA+araC). Total RNAwas isolated by TRIzol (Invitrogen)
extraction and residual genomic DNA contamination was removed
using the TURBO DNA-free kit (Ambion). Cells were transfected with
the RNA preparations described earlier using Attractene (Qiagen).
In vitro transcription
The coding sequence of enhanced green ﬂuorescent protein
(EGFP) was cloned into the pDP19 transcription vector (Ambion).
Single stranded RNA (ssRNA) copies of the EGFP gene were
transcribed in the 5′–3′ and 3′–5′ direction and treated with DNase
192 C. Myskiw et al. / Virology 413 (2011) 183–193using the MEGAscript T3/T7 kit (Ambion). SsRNAs were puriﬁed
following transcription using the RNeasy kit (Qiagen). Equal amounts
of T3 and T7 transcribed RNA were annealed together at 37 °C for 1 h
to produce a double-stranded (ds) EGFP RNA of approximately
800 base-pairs.
RNase A digests
3 μg of ssEGFP or dsEGFP RNA or 3 μg of vaccinia late RNA was
incubated at 37 °C for 1 h with RNase A digestion buffer containing
10 mM Tris–HCl, 10 mM EDTA, 400 mM NaCl, pH7.9, in the absence
(mock digested) or presence (RNase A digested) of 100 ng of recom-
binant RNase A (Ambion). Electrophoresis was carried out on an RNA
gel using the NorthernMax system (Ambion).
Western blotting
Cells were collected in 1 mL of PBS and pelleted by centrifugation
at 6000 rpm for 2 min. Cell pellets were lysed in 200 μL of 1×Laemmli
buffer. Protein samples were separated on Criterion XT pre-cast gels
(Bio-Rad) and transferred to Hybond-C nitrocellulose membranes
(Amersham Bioscience). Membranes were developed with Western
Lightning Chemiluminescent Reagent Plus (Perkin Elmer) or Immo-
bilon Western Chemiluminescent HRP Substrate (Millipore).
Reverse transcription PCR
RNA was extracted using the RNeasy Mini Kit (Qiagen). RT-PCR was
performed on 1 μg of RNA using the Quantitect reverse transcription kit
(Qiagen). PCR was performed using GoTaq Green (Promega). The IFN-β
forward primer sequence was 5′-TGTCTCCTCCAAATTGCTCTC-3′
and the reverse primer sequence was 5′-TCCTTGGCCTTCAGG-
TAATG-3′. The GAPDH forward primer sequence was 5′-AAGGT-
GAAGGTCGGAGTCAA-3′ and the reverse primer sequence was
5′-TTACTCCTTGGAGGCCATGT-3′. The D12 forward primer sequence was
5′-ACCTCAGCGCACGCAATAAACTGTTCA-3′ and reverse primer sequence
was 5′-AGTCATACTAGAATAAAGCAGCGAGT-3′. The A1 forward primer
sequence was 5′-ATGGCTAAGCGAGTAAGCCTTCCAGAT-3′ and the re-
verse primer sequence was 5′-TTACAATAAACTCCGTAGAGAAATATC-3′.
The A17 forward primer sequence was 5′-ATGAGTTATTTAAGATATTA-
CAATATGCTT-3′and the reverse primer sequence was 5 -TCGTCAG-
TATTTAAACTGTTAAATGTTGGT-3′.
Real time PCR arrays
The RT2 Proﬁler PCR Array System/Common Human Cytokines
(SuperArray) was used to quantify cytokine mRNA expression. HeLa
cells (~70% conﬂuent) in 6-well plates were transfected with 3 μg of
RNA and collected after 6 h. RNA was extracted using the RNeasy kit
(Qiagen). Residual genomic DNA contamination was removed using
the TURBO DNA-free kit (Ambion). 0.75 μg of RNA from each sample
was reverse transcribed into cDNA using the RT2 First Strand Kit
(SuperArray). Real-time PCRwas performed using the RT2 SYBR Green
qPCR Master Mix (SuperArray) on an ABI 7500 FAST 96-well real time
PCR machine (Applied Biosystems). Results were analyzed using the
PCR Array Data AnalysisWeb Portal (SuperArray). GAPDH and β-actin
were chosen as internal loading controls for sample normalization.
Real time PCR
0.5 μg of RNAwas reverse transcribed using the Quantitect Reverse
transcription kit (Qiagen). Real time PCR was performed using
Taqman Gene Expression Master Mix (Applied Biosystems) on an
ABI 7500 FAST 96-well real time PCR machine (Applied Biosystems).
The actin forward primer sequence was 5′-CACACTGTGCCCATC-
TACGA-3′, the reverse primer sequence was 5′-GCCAGCCAGGTCCA-GAC-3′ and the probe sequence was 5′-CCCATGCCATCCTGC-3′. The
IFN-β forward primer sequence was 5′-TGGCTGGAATGAGAC-
TATTGTTGAG-3′, the reverse primer sequence was 5′-CAG-
GACTGTCTTCAGATGGTTTATCT-3′ and the probe sequence was
5′-CCTCCTGGCTAATGTC-3′. Results show the percent relative expression
of IFN-β, normalized to actin expression, in comparison to control siRNA
treated cells.
Fluorescence activated cell sorting
Semi-conﬂuent HeLa cells in 6-well plates were transfected with
10 μg of late RNA using Attractene. After 12 h, cells were collected by
scraping and centrifuged at 5000 rpm for 5 min. Cell pellets were
washed with 1 mL phosphate buffered saline. Cells were then lysed in
hypotonic propidium iodide buffer containing 0.1% sodium citrate,
0.1% Triton X-100, 50 μg/mL propidium iodide and 100 μg/mL of
RNase A. Following a 30 min incubation in the dark at room temp-
erature, cells were analyzed on a Becton Dickinson FACScalibur ﬂow
cytometer. Propidium iodide ﬂuorescence was collected on the FL3
channel in logarithmic data collection mode. Cellular debris, evident as
particles ofminimal size and ﬂuorescence, was gated out in a dot plot of
forward scatter (FSC) vs. FL3 ﬂuorescence. Nuclei to the left of the G1
peak in the DNA ﬂuorescence histogram were considered apoptotic.
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